Rare Diseases Symptoms Automatic Extraction

Saving orphans: BRAF targeting of histiocytosis.

[erdheim-chester disease]

In this issue of Blood, Haroche and colleagues report significant therapeutic activity of the BRAF inhibitor, vemurafenib, in 3 patients with rare histiocytic conditions, Erdheim-Chester disease and Langerhans cell histiocytosis.